Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients.

Background: We examined the clinical characteristics of hemodialysis patients with COVID-19 during the 6th wave of infection (mainly Omicron variant) in Japan.

Methods: Hemodialysis patients admitted in January 2022 and thereafter were grouped as the 6th wave group ( = 53), while others were grouped as the 1st-5th wave group ( = 47).

Results: The proportion of vaccinations was significantly higher in the 6th wave group than in the 1st-5th wave group (96.

Characteristics of hemodialysis patient with critical COVID-19.

Introduction: The clinical course of hemodialysis patients with COVID-19 still remains unclear.

Methods: Thirty-four hemodialysis patients were retrospectively enrolled. Patients were divided according to disease severity, and clinical symptoms and laboratory data at admission were compared.

Subsp. Induces Specific IgE Production in Japanese People with Allergies.

. The prevalence of allergies is steadily increasing worldwide; however, the pathogenesis is still unclear. We hypothesized that subsp.

Humoral response against host-mimetic homologous epitopes of Mycobacterium avium subsp. paratuberculosis in Japanese multiple sclerosis patients.

Several works have demonstrated the existence of a link between Mycobacterium avium subsp. paratuberculosis (MAP) and MS in Italy. In this study, we analyzed the serology of MAP in a Japanese population while looking at several markers of MAP.

Seroprevalence of IgG1 and IgG4 class antibodies against Mycobacterium avium subsp. paratuberculosis in Japanese population.

Mycobacterium avium subsp. paratuberculosis (MAP) is the established causative agent of Johne's disease in cattle and other ruminants, and it has also been speculated to be a putative etiological agent of several human autoimmune diseases. It is acknowledged that dairy products deriving from infected animals play a role (could be vehicles) in exposing humans to MAP.

Treatment of a serotype-1 hepatitis C virus infection using interferon-beta in a patient with a high RNA titer who had been receiving long-term hemodialysis therapy.

A serotype-1 hepatitis C virus (HCV) infection in a 67-year-old hemodialysis patient was treated using interferon (IFN)-beta. Although the patient had a high RNA titer (5.1 log IU/mL) and had been receiving long-term hemodialysis therapy (30 years), the initial 4-week IFN-beta administration enabled a rapid virological response without any major adverse effects.

Clinical evaluation of liver injury in patients with acute ischemic brain stroke treated with edaravone.

Aim:   To elucidate the etiologic factors and features of liver injury in patients with acute ischemic brain stroke who were treated with edaravone and reported by their attending physicians to have developed serious liver injury.

Methods:   The present study investigated 123 patients with a verified episode of liver injury among 132 patients with serious liver injury that had been reported attributable to edaravone.

Results:   Ischemic and/or congestive liver (70.

Association of peripheral artery disease and long-term mortality in hemodialysis patients.

Background: Peripheral artery disease (PAD) is a common complication in hemodialysis patients. The ankle-brachial blood pressure index (ABI) has been widely used to screen for subclinical PAD. In the present study, we investigated the association between ABI and long-term (up to 8.

Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years.

Background: Dialysis-related amyloidosis is one of the chronic the complications of haemodialysis. We conducted an investigation of dialysis-associated amyloidosis in extremely long-term survivors.

Methods: Twenty-one patients on haemodialysis for more than 30 years ('30+' group) and 13 patients on haemodialysis for 20-30 years ('20-30' group) at Sangenjaya Hospital were enrolled in this study.

Characteristics of patients on hemodialysis therapy for more than 30 years.

Since its experimental introduction in 1960, hemodialysis has become a widely performed and relatively safe procedure. Therapeutic strategies have been developed, and the numbers of long-term survivors of hemodialysis therapy have been increasing. Hemodialysis therapy was introduced at Sangenjaya Hospital in October 1970, and the 16 patients who have survived for more than 30 years on hemodialysis therapy since its introduction at the hospital were enrolled in this study to investigate the characteristics of long-term hemodialysis patients.